Bianchi, P.
Jacques, C.
Theunis, J.
Jamin, E. L.
Orlandi, C.
Cauhape, L.
Alvarez-Georges, S.
Alves, A.
Simcic-Mori, A.
Lauze, C.
Gravier, E.
Carballido, F.
Ribet, V.
Bessou-Touya, S.
Duplan, H.
Article History
Received: 15 July 2024
Accepted: 16 June 2025
First Online: 1 July 2025
Declarations
:
: The authors declare no competing interests.
: This study was performed in accordance with the principles stated in the Declaration of Helsinki and its subsequent amendments (1964, and last amendment in force), and in accordance with the spirit of Good Clinical Practice (GCP) Guideline published by the International Conference on Harmonization (Adopted by CHMP, 15 December 2016, issued as EMA/CHMP/ICH/135/1995). Informed consent was obtained from all subjects. All subjects were anonymized and there is no identifying information that could lead to the identification of a participant in the trial documents or this manuscript. The study adhered to Regulation (EC) No 1223/2009 of the European Commission and the French Decree n°2017āāā884 on research on cosmetic products. According to this law, as the study involved commercially available cosmetic products, approval from an ethics committee was not required. This study is registered in the FDA ClinicalTrials.gov under the trial registration number NCT06387277.